Development of lipid nanoparticles mRNA vaccine against viral Influenza infection

Pattern of Lipid nanoparticle (LNP)- RNA vaccine against Haemophilus influenza type b hcsA and hcsB genes facilitating the transport of capsular polysaccharides across the outer

Development of Lipid Nanoparticles [LNP]-RNA Vaccine Against Neisseria Meningitidis CPS Gene Locus Facilitating the Synthesis of The Capsular Polysaccharide in Egypt

Design of Lipid nanoparticle (LNP)- RNA vaccine against Haemophilus influenza type b hcsA and hcsB genes facilitating the transport of capsular polysaccharides across the outer m

Immunogenicity of Vaccine Encoding Spike Protein against Middle East Respiratory Syndrome Coronavirus in Mammalian Model

Emerging Trends in mRNA Vaccine Technology: Beyond Infectious Diseases

Development of lipid nano particles RNA vaccine against hepatitis B surface antigens of hepatitis B virus

Development of lipid nanoparticles(LNP)- RNA vaccine against <i>Streptococcus pneumoniae</i> gene cluster facilitating the synthesis of the capsular polysaccharide in Egypt.

Live Attenuated and Sub-Unit Vaccines Exploitation Against Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-COV2]

Manufacture and immunogenicity of therapeutic RNA Hepatitis C Virus genotype 4 vaccine by bio-informatics